Loading...
XTSXASG
Market cap25mUSD
Jan 08, Last price  
0.48CAD
1D
2.13%
1Q
74.55%
Jan 2017
152.63%
IPO
-65.22%
Name

Aurora Spine Corp

Chart & Performance

D1W1MN
XTSX:ASG chart
P/E
P/S
1.78
EPS
Div Yield, %
0.00%
Shrs. gr., 5y
10.89%
Rev. gr., 5y
10.83%
Revenues
15m
-2.40%
02,590,5844,900,6256,756,4755,989,1148,682,32111,152,7198,645,62110,544,80714,877,32414,520,436
Net income
-2m
L+11.93%
-1,445,369-7,507,243-2,916,159-1,679,251-2,240,351-68,198-1,254,273-232,085-2,359,325-1,501,466-1,680,563
CFO
-935k
L-39.98%
-1,301,394-7,130,002-3,484,147-1,697,252-1,145,486435,787729309,568-2,129,348-1,557,816-935,061
Earnings
May 12, 2025

Profile

Aurora Spine Corporation, through its subsidiary, Aurora Spine, Inc., engages in the development and distribution of minimally invasive interspinous fusion systems and devices in Canada. The company offers interspinous process lumbar fusion devices, such as the ZIP, ZIP ULTRA, ZIP LP, and ZIP-51 for patients suffering from degenerative disc diseases; and Ti-Coated polyether ether ketone interbody cages, which provide spacing and stability between the vertebrae while bone grows to complete the fusion process. It also provides sterile-packed titanium plasma spray coated spinal infusion implants for bone growth, as well as interbody products, such as EOS, VOX, Echo, Echo SD, and EchoXL for the lumbar section of the spine, and discovery for cervical procedures. In addition, the company provides SOLO, an anterior lumbar interbody fusion 3D printed stand-alone fusion device, which is an integrated plate and spacer system that helps to preserve the natural anatomic profile while providing spinal column support and stability; and SiLo, a posterior fusion device for the sacroiliac joint. Further, it offers DEXA-C, a cervical interbody system, which is a porous 3D-printed intervertebral body fusion device that incorporates low-, mid-, or high-density lattice pattern options to support the matching of patients' bone quality. Aurora Spine Corporation was incorporated in 2013 and is headquartered in Toronto, Canada.
IPO date
Sep 10, 2013
Employees
Domiciled in
CA
Incorporated in
CA

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
14,520
-2.40%
14,877
41.09%
Cost of revenue
14,967
15,352
Unusual Expense (Income)
NOPBT
(446)
(475)
NOPBT Margin
Operating Taxes
231
Tax Rate
NOPAT
(446)
(706)
Net income
(1,681)
11.93%
(1,501)
-36.36%
Dividends
Dividend yield
Proceeds from repurchase of equity
1,410
BB yield
-4.99%
Debt
Debt current
231
197
Long-term debt
4,499
3,327
Deferred revenue
Other long-term liabilities
2
Net debt
3,963
3,100
Cash flow
Cash from operating activities
(935)
(1,558)
CAPEX
(479)
(873)
Cash from investing activities
(479)
(873)
Cash from financing activities
1,758
(318)
FCF
(1,429)
(2,770)
Balance
Cash
767
423
Long term investments
Excess cash
41
Stockholders' equity
5,297
1,123
Invested Capital
8,902
7,290
ROIC
ROCE
EV
Common stock shares outstanding
70,669
66,797
Price
0.40
-12.09%
0.46
31.88%
Market cap
28,268
-6.99%
30,393
50.06%
EV
32,231
33,493
EBITDA
603
394
EV/EBITDA
53.45
85.06
Interest
185
164
Interest/NOPBT